nabumetone and u 0126

nabumetone has been researched along with u 0126 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Abramson, SB; Apsel, B; Chan, ES; Chang, LF; Clancy, R; Dinsell, V; Gomez, P; Marjanovic, N; Pillinger, MH; Tolani, SN1

Other Studies

2 other study(ies) available for nabumetone and u 0126

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Regulation of metalloproteinases and NF-kappaB activation in rabbit synovial fibroblasts via E prostaglandins and Erk: contrasting effects of nabumetone and 6MNA.
    British journal of pharmacology, 2004, Volume: 142, Issue:6

    Topics: Alprostadil; Analysis of Variance; Animals; Butadienes; Butanones; Cell Line; Cell Survival; Cyclooxygenase Inhibitors; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Imidazoles; Interleukin-1; Matrix Metalloproteinase 1; Metalloendopeptidases; Nabumetone; Naphthaleneacetic Acids; NF-kappa B; Nitric Oxide; Nitriles; Phosphorylation; Prostaglandins E; Pyridines; Rabbits; Synovial Membrane; Tumor Necrosis Factor-alpha

2004
chemdatabank.com